Calling all media inquiries! Pay attention to our recent findings and give us a call to talk to the expert directly. Contact our media agency, Finn Partners, to schedule some time to get insightful, unbiased, fact-based answers to your questions.
Sarah Alwardt joins Avalere as the practice director of the Center for Healthcare Transformation.
Two new additions expand expertise in drug pricing, payer engagement, CMS coverage and payment, and strategic market access and commercialization.
Seasoned health policy professional brings significant expertise in federal legislation, drug pricing policy, delivery system reform, and federal and state programs that affect insurance coverage.
Luke Reardon has joined Avalere’s Financial Services Practice as principal, bringing with him 15 years of experience that ranges from financial consulting to pharmacy solutions strategies.
They bring more than 35 years of combined healthcare experience and expertise in the immunization development sector.
He brings more than 30 years’ worth of actuarial and formulary management experience to the firm.
Data-Driven Research Presented at Academy of Managed Care Pharmacy (AMCP), ISPOR Annual Meeting and Key Spring Conferences Powered by Inovalon’s MORE2 Registry® Dataset
At a time when more Americans—particularly people of color—are enrolled in Medicaid, new Avalere analysis finds that provider networks for primary care and certain specialties in Medicaid are narrower on average than those of commercial plans in certain metropolitan areas, ranging from 63% smaller in Miami to 18% in New York.
Each brings leadership and deep experience within the life sciences industry.
He brings significant experience in 3PL, channel and distribution strategies, and innovative market access solutions for life sciences companies to expedite product to patient.
They bring nearly 40 years combined healthcare experience to the firm, with expertise in the health insurance sector.
Avalere analysis finds that the candidates’ healthcare coverage reform proposals could impact a range of 23M to 153M individuals across insurance markets.
New Avalere analysis finds higher premiums for the enhanced standalone drug plans participating in the model.
New Avalere Health analysis of Medicare fee-for-service (FFS) claims data reveals large decreases in skilled nursing facility (SNF) and home health care use following the widespread decline in inpatient hospitalizations amid the response to the COVID-19 pandemic. Avalere’s analysis further suggests that as inpatient procedures resume in some areas, the volume of inpatient hospital discharges to home health is starting to rebound, whereas the volume of discharges to SNF remains below 2019 levels.
Avalere analysis finds that at least 5 million Black and Hispanic people may lose their health insurance as a result of the pandemic.
Hafez expands Avalere's market access capabilities with deep expertise in strategy, operations, commercialization, and analytics.
He brings healthcare tech, data, advocacy, and strategy experience to the firm.
She deepens the firm’s post-acute and policy analytics capabilities, bringing nearly 15 years' worth of policy analytics experience to Avalere with a specific focus on the provider sector.
Recent Avalere analysis finds decreases in utilization of oncology and autoimmune treatments across all care settings since the onset of the health crisis.
Two new hires come to the firm with significant experience in US healthcare.